Koyfin Home > Directory > Health Care > Amphastar Pharma > EV / Sales (ltm)

Amphastar Pharma EV / Sales (ltm) Chart (AMPH)

Amphastar Pharma annual/quarterly EV / Sales (ltm) from 2014 to 2018.
  • Amphastar Pharma EV / Sales (ltm) for the quarter ending March 03, 2018 was 3.53 a 12.97% increase of 0.46 year over year
  • Amphastar Pharma Annual EV / Sales (ltm) for 2017 was 3.55 a 13.65% increase of 0.48 from 2016
  • Amphastar Pharma Annual EV / Sales (ltm) for 2016 was 3.06 a 12.79% increase of 0.39 from 2015
  • Amphastar Pharma Annual EV / Sales (ltm) for 2015 was 2.67 a 11.26% increase of 0.30 from 2014
Other Valuation Metrics:
  • Amphastar Pharma Market Cap for the quarter ending March 03, 2018 was $869m a 6.01% increase of 52m year over year
  • Amphastar Pharma Price / Book for the quarter ending March 03, 2018 was 2.59 a 2.71% increase of 0.07 year over year
  • Amphastar Pharma Enterprise Value for the quarter ending March 03, 2018 was $848m a 8.52% increase of 72m year over year
View Chart On Koyfin

Quarterly AMPH EV / Sales (ltm) Data

03/20183.53
12/20173.55
09/20173.16
06/20173.07
03/20172.47
12/20163.06
09/20163.10
06/20162.76
03/20162.04
12/20152.67

Annual AMPH EV / Sales (ltm) Data

20173.55
20163.06
20152.67
20142.37